Cytomos has achieved commercialisation of its first product and has a pipeline of trials planned with global partners, along with strong interest from high-profile technology developers and a top ten pharma company.
Company Description
Cytomos is a biotech company that has developed a cell analysis technology platform called AuraCyt, which enhances single-cell analysis and aims to transform biological drug discovery and manufacturing processes.
Market
Drug Discovery
Location
Edinburgh,
Scotland,
United Kingdom
Coinvestors
Archangels, Old College Capital, Scottish Enterprise, British Business Bank